Bio Essence (BIOE) Non-Current Debt (2020 - 2024)
Bio Essence (BIOE) recorded quarterly Non-Current Debt of $608631.0 in Q1 2024, up 3898.63% quarter-over-quarter from $15221.0 in Q4 2023, and up 2637.14% on a YoY basis from $22236.0 in Q2 2023.
Bio Essence (BIOE) Non-Current Debt (2020 - 2024) Analysis & Trends
Bio Essence's Non-Current Debt history runs 5 years deep, the most recent figure standing at $608631.0 for Q1 2024.
- In Q1 2024, Non-Current Debt rose 2637.14% year-over-year to $608631.0; the TTM figure through Mar 2024 stood at $608631.0 (up 2637.14% YoY), while the FY2023 annual figure was $15221.0, down 40.45% from the prior year.
- Non-Current Debt was $608631.0 for Q1 2024 at Bio Essence, up from $15221.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $608631.0 in Q1 2024 to a low of $14549.0 in Q2 2021.
- Historically, Non-Current Debt has averaged $94286.4 across 5 years, with a median of $30355.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Non-Current Debt sank 83.48% in 2022, then soared 2637.14% in 2024.
- A 5-year view of Non-Current Debt shows it stood at $212750.0 in 2020, then slumped by 82.18% to $37918.0 in 2021, then plunged by 32.59% to $25561.0 in 2022, then tumbled by 40.45% to $15221.0 in 2023, then soared by 3898.63% to $608631.0 in 2024.
- The last three Non-Current Debt figures came in at $608631.0 (Q1 2024), $15221.0 (Q4 2023), and $17288.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 608,631.00 |
| Mar 31, 2024 | 608,631.00 |
| Dec 31, 2023 | 15,221.00 |
| Dec 31, 2023 | 15,221.00 |
| Sep 30, 2023 | 17,288.00 |
| Sep 30, 2023 | 17,288.00 |
| Jun 30, 2023 | 19,304.00 |
| Jun 30, 2023 | 19,304.00 |
| Mar 31, 2023 | 22,236.00 |
| Mar 31, 2023 | 22,236.00 |
| Dec 31, 2022 | 25,561.00 |
| Dec 31, 2022 | 25,561.00 |
| Sep 30, 2022 | 28,788.00 |
| Sep 30, 2022 | 28,788.00 |
| Jun 30, 2022 | 31,922.00 |
| Jun 30, 2022 | 31,922.00 |
| Mar 31, 2022 | 34,964.00 |
| Mar 31, 2022 | 34,964.00 |
| Dec 31, 2021 | 37,918.00 |
| Dec 31, 2021 | 37,918.00 |